Check-Cap 'publicly condemned' MediPharm Labs, Chairman Chris Taves
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 04 2025
0mins
Check-Cap's Response to MediPharm Labs: Check-Cap publicly condemned MediPharm Labs and its Chairman, Chris Taves, for spreading false and misleading statements about the company during a sensitive time for Israeli businesses, claiming these actions are unethical and unlawful.
Allegations of Market Manipulation: Check-Cap accuses Mr. Taves of using his position to manipulate their stock price by making baseless accusations regarding their public disclosures, and demands a retraction and apology from both MediPharm Labs and Mr. Taves.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
